NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, announced today that Barry Weiner, President, and David Goldberg, Vice President, Corporate Development, will be presenting at the Thomas Weisel Partners 2009 Healthcare Conference on Friday September 11, 2009, at 8:35 AM E.T. at The Four Seasons Hotel in Boston, MA.
